143 related articles for article (PubMed ID: 22961938)
21. Selective α1B- and α1D-adrenoceptor antagonists suppress noradrenaline-induced activation, proliferation and ECM secretion of rat hepatic stellate cells in vitro.
Liu TT; Ding TL; Ma Y; Wei W
Acta Pharmacol Sin; 2014 Nov; 35(11):1385-92. PubMed ID: 25283507
[TBL] [Abstract][Full Text] [Related]
22. Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells.
Han Z; Ma Y; Cao G; Ma Z; Chen R; Cvijic ME; Cheng D
Biochem J; 2021 May; 478(9):1689-1703. PubMed ID: 33876829
[TBL] [Abstract][Full Text] [Related]
23. Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.
Zhang YQ; Wan LY; He XM; Ni YR; Wang C; Liu CB; Wu JF
DNA Cell Biol; 2017 Jul; 36(7):603-610. PubMed ID: 28467108
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
[TBL] [Abstract][Full Text] [Related]
25. Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathway.
Zheng J; Wu C; Xu Z; Xia P; Dong P; Chen B; Yu F
Mol Cell Biochem; 2015 Jan; 398(1-2):1-9. PubMed ID: 25148875
[TBL] [Abstract][Full Text] [Related]
26. n-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells.
Hu S; Bae M; Park YK; Lee JY
J Nutr Biochem; 2020 Nov; 85():108452. PubMed ID: 32745880
[TBL] [Abstract][Full Text] [Related]
27. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
28. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
29. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
30. New role and molecular mechanism of Gadd45a in hepatic fibrosis.
Hong L; Sun QF; Xu TY; Wu YH; Zhang H; Fu RQ; Cai FJ; Zhou QQ; Zhou K; Du QW; Zhang D; Xu S; Ding JG
World J Gastroenterol; 2016 Mar; 22(9):2779-88. PubMed ID: 26973416
[TBL] [Abstract][Full Text] [Related]
31. Curcumin inhibits aerobic glycolysis in hepatic stellate cells associated with activation of adenosine monophosphate-activated protein kinase.
Lian N; Jin H; Zhang F; Wu L; Shao J; Lu Y; Zheng S
IUBMB Life; 2016 Jul; 68(7):589-96. PubMed ID: 27278959
[TBL] [Abstract][Full Text] [Related]
32. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.
Guo GH; Tan DM; Zhu PA; Liu F
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):59-64. PubMed ID: 19208517
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells.
Bataller R; Paik YH; Lindquist JN; Lemasters JJ; Brenner DA
Gastroenterology; 2004 Feb; 126(2):529-40. PubMed ID: 14762790
[TBL] [Abstract][Full Text] [Related]
35. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
36. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.
Patra T; Sasaki R; Meyer K; Ray RB; Ray R
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243135
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of estrogen receptor β inhibits cellular functions of human hepatic stellate cells and promotes the anti-fibrosis effect of calycosin via inhibiting STAT3 phosphorylation.
Wang Y; Wu C; Zhou J; Fang H; Wang J
BMC Pharmacol Toxicol; 2022 Oct; 23(1):77. PubMed ID: 36207725
[TBL] [Abstract][Full Text] [Related]
38. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
Wu SM; Li TH; Yun H; Ai HW; Zhang KH
Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor γ inhibits hepatic stellate cell activation regulated by miR-942 in chronic hepatitis B liver fibrosis.
Tao L; Wu L; Zhang W; Ma WT; Yang GY; Zhang J; Xue DY; Chen B; Liu C
Life Sci; 2020 Jul; 253():117572. PubMed ID: 32201276
[TBL] [Abstract][Full Text] [Related]
40. IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner.
Fabre T; Kared H; Friedman SL; Shoukry NH
J Immunol; 2014 Oct; 193(8):3925-33. PubMed ID: 25210118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
